- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06297057
Acquisition and Analysis Protocol Optimization of Neurophysiological Data Neurorehabilitation Settings (MEEGOPTI)
Acquisition and Analysis Protocol Optimization of Neurophysiological Data in Neurorehabilitation Setting: Pilot Study on Healthy Subjects
The study aims to optimize and validate protocols for acquiring neurophysiological data, specifically resting state functional connectivity, using advanced research techniques (hdEEG and MEG) and a user-friendly device (MUSE). Previous studies have extensively explored functional connectivity repeatability in resting conditions using functional MRI, yet few have focused on hdEEG and MEG data. Additionally, the impact of subjects' eye conditions (open or closed) during resting state recordings on network identification remains debated.
The investigation involves assessing the effect of eye conditions on brain network identification and determining the most stable and repeatable measures of functional connectivity over time. This analysis is crucial for discerning whether observed changes in patients' functional connections are intrinsic to the methodology or indicative of genuine physiological alterations.
The study aims to optimize protocols for rehabilitation by evaluating changes in functional connectivity metrics during and between experimental sessions. Furthermore, it seeks to identify the conditions (eyes closed or open) that yield more reliable and repeatable functional measurements.
Following the optimization of advanced techniques, the study explores the feasibility of utilizing the MUSE EEG system in clinical settings. MUSE, known for its portability and user-friendliness, has demonstrated quality in experimental psychology and clinical research. The objective is to establish relevant functional correspondences between measurements obtained through research techniques (hdEEG and MEG) and those acquired with MUSE.
The primary goal is to establish a protocol highlighting subjects' responses to acoustic stimuli or a reproducible pattern of resting state activity. The secondary objectives include investigating temporal and spatial characteristics of neurophysiological signals in healthy subjects over time and defining prognostic biomarkers for monitoring patients undergoing rehabilitation. This comprehensive approach aims to enhance the understanding of resting state functional connectivity and its applications in clinical settings.
Therefore, to meet these goals, the present study will consist of multiple recordings of brain activity: by high-density electroencephalography (hdEEG), magnetoencephalography (MEG), and low-density EEG with a MUSE handheld device, during five experimental blocks on healthy subjects.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants who will be identified as suitable for hdEEG, MEG, and MUSE recording will first undergo a neuronavigation session, and then three identical neurophysiological data acquisition sessions, one for hdEEG, one for MEG, and one for MUSE.
The sessions will take place in three consecutive weeks, once a week, taking care that these recordings are made at the same time of day for each participant. Finally, a structural magnetic resonance imaging (MRI) recording will be obtained for each participant.
Each neurophysiological data acquisition session will consist of 5 blocks: 4 eyes-open and eyes-closed resting-state blocks, and one passive auditory stimulation block.
The four blocks in the resting condition will always be performed first, to avoid interference due to the passive acoustic task. The order of blocks 1 and 2, and consequently also blocks 3 and 4, representing the open-eye and closed-eye conditions will be counterbalanced between participants and between different sessions for the same participant.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Venice
-
Venice-Lido, Venice, Italy, 30126
- San Camillo IRCCS s.r.l.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age between 18 and 65
- ability to sign an informed consent form
Exclusion Criteria:
- has suffered/is suffering from epileptic seizures.
- has had severe neurological or psychiatric disorders
- has eyesight problems that prevent him/her from reading, which she cannot correct with contact lenses (she will not be able to wear glasses during registration)
- habitually abused drugs or abused alcoholic substances
- has abused substances such as alcohol or drugs in the last three days
- is a wearer of hearing aids
- has metal and/or skull clips or other metal in any part of the head except the mouth
- has non-removable tattoos
- has piercings, earrings or other metal accessories that cannot be removed.
- is or could be pregnant (pregnancy in the first trimester)
- is a carrier of sickle cell anaemia
- is a cardiac pacemaker wearer or has an artificial heart valve
- has mechanical devices that he/she uses to administer medication
- has a surgical clip (vascular clips and metallic arterial prostheses made of ferromagnetic material)
- has a cochlear implant, a neurostimulator or a programmable hydrocephalic electrical conductor (shunt)
- has had brain surgery
- has implants or metal fragments in the body
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Neurophysiological Recordings
Participants suitable for hdEEG, MEG, and MUSE recordings will first undergo a neuronavigation session, and then three identical neurophysiological data acquisition sessions, one for hdEEG, one for MEG, and one for MUSE. The sessions will take place in three consecutive weeks, once a week, taking care that they are made at the same time of day for each participant. Finally, a structural magnetic resonance imaging (MRI) recording will be obtained for each participant. Each neurophysiological data acquisition session will consist of 5 blocks: 4 eyes-open and eyes-closed resting-state blocks, and one passive auditory stimulation block. The four blocks in the resting condition will be performed first, to avoid interference due to the passive acoustic task. The order of blocks 1 and 2, and consequently also blocks 3 and 4, representing the open-eye and closed-eye conditions will be counterbalanced between subjects and between different sessions for the same subject. |
Eyes-open resting-state blocks: these blocks will last 5 minutes each. Subjects will be asked to relax and not think about anything specific, keeping their eyes open and staring at a white cross in the center of a light grey screen to limit their eye movements. Eyes-closed resting-state blocks: these blocks will last 5 minutes each. Subjects will be asked to relax and not think about anything specific, keeping their eyes closed. ASSR: this block will last approximately 6 minutes. Stimuli will consist of a train of sounds presented repeatedly at high frequency. MMN: this block will last approximately 3 minutes. Stimuli will consist of a train of equal sounds presented alternating with a 'deviant' (rarer frequency) sound. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurophysiological data acquisition protocol - resting state
Time Frame: T1: first week, T2: second week, T3: third week
|
Resting state measure from MEEG data: Power spectrum density values (delta, theta, alpha, beta, gamma frequency)
|
T1: first week, T2: second week, T3: third week
|
|
Neurophysiological data acquisition protocol - resting state
Time Frame: T1: first week, T2: second week, T3: third week
|
Resting state measure from MEEG data: Connectivity values at source level (delta, theta, alpha, beta, gamma frequency)
|
T1: first week, T2: second week, T3: third week
|
|
Neurophysiological data acquisition protocol - auditory stimulation
Time Frame: T1: first week, T2: second week, T3: third week
|
ASSR response (as measured from auditory stimulation)
|
T1: first week, T2: second week, T3: third week
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2021.07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Neurophysiological Recordings
-
VA Office of Research and DevelopmentNot yet recruitingCognitive Impairment | High Fall RiskUnited States
-
University Hospital, Clermont-FerrandNEURO-DOL (UMR 1107 INSERM / UCA)Recruiting
-
University Hospital, GrenobleNot yet recruitingSevere Psychiatric Disorders
-
Istinye UniversityYasemin Çırak; Gül Deniz YILMAZ YELVAR; Serap İNAL; Nurgül DÜRÜSTKAN ELBAŞICompletedHemiplegia,Stroke, Respiratory, Neurophysiological Facilitation TechniquesTurkey
-
ozden erkanMemorial Sisli Hospital, Istanbul; Florence Nightingale Hospital, IstanbulCompleted
-
University of ZurichEnrolling by invitationPatients Operated on at the Neurosurgery DepartmentSwitzerland
-
Asir John SamuelUnknownNeonatal Respiratory Distress SyndromeIndia
-
Groupe Hospitalier Paris Saint JosephTerminated
-
Ahram Canadian UniversityRecruitingCervicogenic HeadacheEgypt
-
Qompium NVRecruiting